Amundi
BNTX icon

Amundi’s BioNTech BNTX Stock Holding History

Amundi’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Buy
180,927
+51,414
+40% +$4.84M ﹤0.01% 808
2026
Q1 		$11.5M Buy
129,513
+25,506
+25% +$2.62M ﹤0.01% 859
2025
Q4 		$9.9M Buy
104,007
+18,776
+22% +$1.89M ﹤0.01% 940
2025
Q3 		$8.96M Sell
85,231
-66,512
-44% -$7.11M ﹤0.01% 884
2025
Q2 		$16.4M Sell
151,743
-116,594
-43% -$11.8M 0.01% 742
2025
Q1 		$24.7M Sell
268,337
-12,676
-5% -$1.42M 0.01% 674
2024
Q4 		$34.3M Sell
281,013
-85,658
-23% -$9.78M 0.01% 632
2024
Q3 		$44.1M Buy
366,671
+92,825
+34% +$8.53M 0.02% 572
2024
Q2 		$21.9M Buy
273,846
+8,034
+3% +$734K 0.01% 684
2024
Q1 		$22.9M Buy
265,812
+18,796
+8% +$1.8M 0.01% 681
2023
Q4 		$26.9M Buy
247,016
+222,724
+917% +$22.4M 0.01% 658
2023
Q3 		$2.52M Buy
24,292
+6,724
+38% +$744K ﹤0.01% 1123
2023
Q2 		$1.89M Buy
17,568
+486
+3% +$54.7K ﹤0.01% 1165
2023
Q1 		$2.15M Buy
17,082
+151
+0.9% +$20.7K ﹤0.01% 1140
2022
Q4 		$2.53M Buy
16,931
+821
+5% +$126K ﹤0.01% 1151
2022
Q3 		$2.21M Buy
16,110
+12,479
+344% +$1.91M ﹤0.01% 1135
2022
Q2 		$561K Buy
3,631
+948
+35% +$145K ﹤0.01% 1255
2022
Q1 		$454K Sell
2,683
-154
-5% -$25.9K ﹤0.01% 1303
2021
Q4 		$576K Sell
2,837
-1,579
-36% -$432K ﹤0.01% 1379
2021
Q3 		$1.21M Buy
4,416
+2,414
+121% +$767K ﹤0.01% 1264
2021
Q2 		$448K Buy
+2,002
New +$378K ﹤0.01% 1284

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Amundi's BNTX Position: Q2 2026 in Review

Amundi increased its BioNTech (BNTX) stake by 40% in Q2 2026, buying an estimated $4.84M and bringing the position to 180,927 shares worth $16.8M. The position accounts for ﹤0.01% of the portfolio, ranked #808.

Amundi first reported a position in BNTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $44.1M in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Amundi held 180,927 shares of BioNTech worth $16.8M as of Q2 2026.
  • Amundi bought 51,414 BioNTech shares in Q2 2026, an estimated $4.84M.
  • BioNTech made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #808 holding.
  • Amundi first reported a position in BioNTech in Q2 2021 and has held it in 21 quarters since.
  • Amundi's BioNTech position peaked at $44.1M in Q3 2024.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.